Conference Coverage (Montreal)
Recombinant Hemoglobin Looks Good for Restoring Oxygen after Hemorrhage
Published in Blood Weekly, September 16th, 1996
Currently, recombinant human hemoglobin (Optro) is in clinical trials to evaluate its use in a setting of intraoperative blood loss, noted Michael P. Doyle, Somatogen, Inc., Boulder, Colorado, while addressing participants attending the VI International Symposium on Blood Substitutes, held August 5-7, 1996, at McGill University, in Montreal, Quebec, Canada.
Somatogen recently had developed an animal model to determine the efficacy of their product during resuscitation from hemorrhagic shock.
"The hemorrhage protocol used in this study is sufficient to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1996-09-16)
More Articles from Blood Weekly
- Conference Coverage (Montreal)
Recombinant Hemoglobin Safely Used in Hemodilution - Blood Banking (Legal Issues)
Claim Forms Mailed in HIV Class Action Settlement - Blood Banking (Legal Issues)
Principles Agreed Upon for HCV/HIV Compensation Plan - Conference Coverage (Montreal)
Viral Inactivation Achieved by Heat Treating Crosslinked Hemoglobin - Angiogenesis
Arterial Gene Transfer Stimulates Angiogenesis in Patient's Ischaemic Limb - Anticoagulants
Drug Reduces Life-Threatening Blood Clots in Trauma Patients - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
